Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
Director departure
CC transcript
|
|
ALBIREO PHARMA, INC. (ALBO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/27/2023 |
4/A
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 195,000 shares
@ $0 |
|
| 01/27/2023 |
4/A
| Mattsson Jan (Chief Scientific Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 55,000 shares
@ $0 |
|
| 01/27/2023 |
4/A
| Carter Martha J. (Chief Regulatory Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 55,000 shares
@ $0 |
|
| 01/27/2023 |
4/A
| Duncan Jason (Chief Legal Officer and GC) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 55,000 shares
@ $0 |
|
| 01/27/2023 |
4/A
| Graham Michelle (Chief Human Resources Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 32,000 shares
@ $0 |
|
| 01/27/2023 |
4/A
| Harford Simon N.R. (CFO and Treasurer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 55,000 shares
@ $0 |
|
| 01/27/2023 |
4/A
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 55,000 shares
@ $0 |
|
| 01/27/2023 |
4/A
| STRECK PAUL (Chief Medical Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 55,000 shares
@ $0 |
|
| 01/09/2023 |
4/A
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 469 shares
@ $19.0614, valued at
$8.9k
|
|
| 01/09/2023 |
4/A
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 106 shares
@ $24.6713, valued at
$2.6k
|
|
| 01/09/2023 |
4/A
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 919 shares
@ $19.5764, valued at
$18k
|
|
| 03/05/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/25/2021 |
4/A
| Harford Simon N.R. (CFO and Treasurer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 110 shares
@ $37.3322, valued at
$4.1k
|
|
| 02/07/2018 |
4/A
| Phase4 Partners Ltd (10% Owner) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 98,500 shares
@ $34.4006, valued at
$3.4M
Sold 1,500 shares
@ $37.0587, valued at
$55.6k
|
|
| 11/08/2012 |
4/A
| Bavier Paul S (General Counsel/Corp. Sec.) has filed a Form 4 on Biodel Inc |
| 10/03/2011 |
4/A
| URCIUOLI J ARTHUR (Director) has filed a Form 4 on Biodel Inc|
Txns:
| Bought 10,000 shares
@ $1.18, valued at
$11.8k
|
|
| 04/20/2011 |
4/A
| Casey Donald M Jr. (Director) has filed a Form 4 on Biodel Inc |
| 04/20/2011 |
4/A
| Steiner Solomon (10% Owner) has filed a Form 4 on Biodel Inc |
| 10/12/2010 |
4/A
| LIEBERMAN IRA (Director) has filed a Form 4 on Biodel Inc|
Txns:
| Granted 1,969 restricted stock units
@ $0 |
|
| 10/12/2010 |
4/A
| URCIUOLI J ARTHUR (Director) has filed a Form 4 on Biodel Inc|
Txns:
| Granted 1,969 restricted stock units
@ $0 |
|
|
|